Viewing data from:

ACETAZOLAMIDE

ANDA

ACETAZOLAMIDE | A207503 | BRECKENRIDGE PHARMACEUTICAL INC

2 strengths0 unique patents0 unique exclusivities

API Supply Chain6 active DMFs3 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

ZAKLADY FARMACEUTYCZNE POLPHARMA SAACETAZOLAMIDE

DMF 103831993

IDT AUSTRALIA LTDACETAZOLAMIDE USP

DMF 129971998

NAKODA CHEMICALS LTDACETAZOLAMIDE

DMF 197632006

EMCURE PHARMACEUTICALS LTDACETAZOLAMIDE USP

DMF 202992007

CTX LIFE SCIENCES PVT LTDACETAZOLAMIDE USP

DMF 230142009

GLAND PHARMA LTDACETAZOLAMIDE

DMF 376162022

KV PHARMACEUTICAL COInactiveACETAZOLAMIDE 500MG SRC

DMF 25611975

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveACETAZOLAMIDE

DMF 28331977

CAMBREX PROFARMACO MILANO SRLInactiveACETAZOLAMIDE

DMF 46471982

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 125MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 30, 2020

No patent or exclusivity listings for this strength.

#002 — 250MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 30, 2020